Related Experiment Video
Updated: Aug 16, 2026
09:30
Precision Induction and Distinction of Coughing and Sneezing Reflexes in Mice
Published on: October 3, 2025
New Products
Science (New York, N.Y.)
|August 14, 2026
Summary
Researchers can discover new laboratory instrumentation, apparatus, and materials weekly. This roundup highlights the latest offerings to advance scientific research and development.
Area of Science:
- Laboratory Science
- Research Equipment
Background:
- The rapid advancement of scientific research necessitates access to cutting-edge tools.
- Keeping abreast of new laboratory instrumentation and materials is crucial for researchers.
Purpose of the Study:
- To provide a consolidated weekly overview of novel laboratory instrumentation.
- To inform researchers about newly available apparatus and materials.
- To facilitate the adoption of innovative tools in research settings.
Main Methods:
- Compilation of information on newly offered products.
- Categorization of laboratory materials and instrumentation.
- Weekly dissemination of findings to the research community.
Main Results:
- A curated list of new laboratory instrumentation is presented.
- Information on novel apparatus and materials is made available.
- Researchers are informed about the latest scientific supplies.
Conclusions:
- This weekly roundup serves as a valuable resource for researchers.
- Access to new instrumentation and materials can accelerate scientific discovery.
- The information aims to support and enhance laboratory research efforts.
Related Concept Videos
01:26FDA Approved Drugs: Changes to Approved Drugs
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
02:27Predicting Products: SN1 vs. SN2
Nucleophilic substitution reactions of alkyl halides can proceed via an SN1 or an SN2 mechanism. While in SN2 reactions, the nucleophile attacks the substrate simultaneously as the leaving group departs, in SN1 reactions, the substrate first dissociates to give the carbocation intermediate. Various factors such as the structure of the substrate, the strength of the nucleophile, and the nature of the solvent promote one mechanism over the other.
With increased substitution on the alkyl halide,...
With increased substitution on the alkyl halide,...
02:52Predicting Products: Substitution vs. Elimination
When a nucleophile and an alkyl halide react, nucleophilic substitution and β-elimination reactions compete to generate products.
The following factors can influence the mechanisms competing against each other:
The following factors can influence the mechanisms competing against each other:
01:28Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
01:26Pharmaceutical Equivalents
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.